Collegium Pharmaceutical, Inc. Revenue 2013–2025
Collegium Pharmaceutical, Inc. reported $780.57M of revenue for fiscal 2025. That was 23.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +151.8%.
| Fiscal year | Revenue | Change (YoY) |
|---|---|---|
| FY 2025 | $780.57M | +23.6% |
| FY 2024 | $631.45M | +11.4% |
| FY 2023 | $566.77M | +22.2% |
| FY 2022 | $463.93M | +67.6% |
| FY 2021 | $276.87M | -10.7% |
| FY 2020 | $310.02M | +4.5% |
| FY 2019 | $296.70M | +5.8% |
| FY 2018 | $280.41M | +884.7% |
| FY 2017 | $28.48M | +1564.3% |
| FY 2016 | $1.71M | — |
| FY 2015 | $0 | — |
| FY 2014 | $0 | — |
| FY 2013 | $0 | — |
Source: Collegium Pharmaceutical, Inc. SEC filings — income statement (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open COLL 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
Collegium Pharmaceutical, Inc. reported $780.57M of revenue for fiscal 2025. That was 23.6% higher than fiscal 2024. Compared with fiscal 2020, the change was +151.8%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for Collegium Pharmaceutical, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeCollegium Pharmaceutical, Inc. — frequently asked questions
What is Collegium Pharmaceutical, Inc.'s revenue?
Collegium Pharmaceutical, Inc. (COLL) reported revenue of $780.57M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Collegium Pharmaceutical, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.